S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSE:MD

Pediatrix Medical Group (MD) Stock Price, News & Analysis

$10.03
+0.04 (+0.40%)
(As of 03/28/2024 ET)
Today's Range
$9.97
$10.18
50-Day Range
$8.46
$10.03
52-Week Range
$7.70
$15.20
Volume
641,747 shs
Average Volume
725,270 shs
Market Capitalization
$843.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.30

Pediatrix Medical Group MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
2.7% Upside
$10.30 Price Target
Short Interest
Bearish
4.85% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.61mentions of Pediatrix Medical Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.68%
From $1.12 to $1.15 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.37 out of 5 stars

Medical Sector

907th out of 938 stocks

Hospitals Industry

3rd out of 3 stocks

MD stock logo

About Pediatrix Medical Group Stock (NYSE:MD)

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

MD Stock Price History

MD Stock News Headlines

[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
Recap: Pediatrix Medical Group Q4 Earnings
Pediatrix Medical Group Reports Fourth Quarter Results
Earnings Preview For Pediatrix Medical Group
Your Guide to Baby Sleep Regressions
See More Headlines
Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/20/2024
Today
3/28/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospitals
Sub-Industry
Health Care Services
CUSIP
58502B10
Employees
5,170
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$10.30
High Stock Price Target
$14.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+2.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$-60,410,000.00
Pretax Margin
-2.42%

Debt

Sales & Book Value

Annual Sales
$1.99 billion
Cash Flow
$1.64 per share
Book Value
$10.10 per share

Miscellaneous

Free Float
82,441,000
Market Cap
$843.72 million
Optionable
Optionable
Beta
1.56

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. James D. Swift M.D. (Age 62)
    CEO & Director
    Comp: $549.53k
  • Mr. C. Marc Richards (Age 53)
    Executive VP & CFO
    Comp: $509.58k
  • Ms. Mary Ann E. Moore (Age 64)
    Executive VP, General Counsel & Secretary
    Comp: $542.02k
  • Dr. Curtis B. Pickert M.D. (Age 66)
    Executive VP & COO
  • Mr. John C. PepiaMr. John C. Pepia (Age 61)
    Senior VP & Chief Accounting Officer
    Comp: $931.2k
  • Ms. Cheryl M. VanPatten
    Senior VP & Chief Information Officer
  • Mr. Daniel Patrick Corcoran
    Senior Vice President of Administration & Managed Care
  • Mr. Charles W. Lynch C.F.A.
    Senior VP of Finance, Strategy & Investor Relations
  • Ms. Meghan K. Lublin
    Senior VP, Chief Brand & Communications Officer
  • Mr. Lee A. Wood (Age 56)
    Executive Vice President of National & Market Operations

MD Stock Analysis - Frequently Asked Questions

Should I buy or sell Pediatrix Medical Group stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.
View MD analyst ratings
or view top-rated stocks.

What is Pediatrix Medical Group's stock price target for 2024?

4 Wall Street analysts have issued 1 year price targets for Pediatrix Medical Group's stock. Their MD share price targets range from $9.00 to $14.00. On average, they expect the company's share price to reach $10.30 in the next twelve months. This suggests a possible upside of 2.7% from the stock's current price.
View analysts price targets for MD
or view top-rated stocks among Wall Street analysts.

How have MD shares performed in 2024?

Pediatrix Medical Group's stock was trading at $9.30 at the beginning of 2024. Since then, MD shares have increased by 7.8% and is now trading at $10.03.
View the best growth stocks for 2024 here
.

Are investors shorting Pediatrix Medical Group?

Pediatrix Medical Group saw a increase in short interest in March. As of March 15th, there was short interest totaling 4,030,000 shares, an increase of 25.2% from the February 29th total of 3,220,000 shares. Based on an average daily volume of 732,700 shares, the short-interest ratio is currently 5.5 days. Currently, 4.9% of the company's stock are sold short.
View Pediatrix Medical Group's Short Interest
.

When is Pediatrix Medical Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our MD earnings forecast
.

How were Pediatrix Medical Group's earnings last quarter?

Pediatrix Medical Group, Inc. (NYSE:MD) issued its earnings results on Tuesday, February, 20th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.02. The firm had revenue of $496.44 million for the quarter, compared to the consensus estimate of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive trailing twelve-month return on equity of 10.35%. The company's quarterly revenue was down 3.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.46 EPS.

What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?

6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pediatrix Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

Who are Pediatrix Medical Group's major shareholders?

Pediatrix Medical Group's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (12.37%), Vanguard Group Inc. (12.36%), Dimensional Fund Advisors LP (5.25%), Pacer Advisors Inc. (3.85%), Charles Schwab Investment Management Inc. (1.94%) and Invenomic Capital Management LP (1.64%). Insiders that own company stock include James D Swift, John C Pepia, Mark S Ordan, Mary Ann E Moore, Roger Mack Hinson, Roger Md Medel and Shirley A Weis.
View institutional ownership trends
.

How do I buy shares of Pediatrix Medical Group?

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MD) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners